Parenteral Drugs (India) has informed that meeting of the Board of Directors of the company held on Friday, the 22nd day of December, 2017 considered and approved to seek approval of shareholders by way of postal ballot in terms of section 180 and 188 of the Companies Act, 2013, the Rules framed there under and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for sale/transfer of Kasrawad and WFI undertakings of the Company on slump sale basis to Infutec Healthcare and sale/transfer of investment of the Company equity shares of Infutec Healthcare and for the said purpose, the record date for dispatch of Notice of Postal Ballot is 22nd December, 2017. For the said purpose, the record date for dispatch of Notice of Postal Ballot is 22nd December, 2017.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: